Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies

Medicine & Life Sciences

• factor V Leiden 100%
• Antiphospholipid Antibodies 95%
• Prothrombin 89%
• Thrombosis 58%
• Mutation 42%
• Genes 30%
• Anticardiolipin Antibodies 15%
• Lupus Coagulation Inhibitor 15%
• Venous Thrombosis 11%
• Hypertension 7%
• Factor V 7%
• Varicose Veins 6%
• Oral Contraceptives 6%
• Hyperlipidemias 5%
• Cigarette Smoking 5%
• Restriction Fragment Length Polymorphisms 5%
• Blood Cells 4%
• Hospitalization 4%
• Regression Analysis 3%
• Logistic Models 3%
• Pregnancy 3%
• Polymerase Chain Reaction 3%
• DNA 3%
• Antibodies 3%
• Wounds and Injuries 2%
• Neoplasms 1%